WAGNER CHARLES F JR (EVP and CFO) sold 27.1% of their position (14K shares) of VERTEX PHARMACEUTICALS INC / MA on the open market
Open‑market sale worth $6.38M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 12/5/2025ACC: 0000875320-25-000247
Officer· EVP and CFO
Since Apr 2019
-14K
Net shares
Net seller
$6.38M
Total sold
2
Open market trades
0B · 2S
2
Total transactions
14K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−7K
Price / share
$451.00
Trade value
$3.16M
% of position
13.5%
12/3/2025
51.73K→44.73K
Common Stock
Direct
Shares
−7K
Price / share
$461.00
Trade value
$3.23M
% of position
15.7%
12/3/2025
44.73K→37.73K
Total
Net shares
−14K
Net value
-$6.38M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/3/2025 | S · Sale | −7K | $451.00 | $3.16M | 13.5% | 51.73K | 44.73K |
| Common Stock Direct | 12/3/2025 | S · Sale | −7K | $461.00 | $3.23M | 15.7% | 44.73K | 37.73K |
| Total | −14K | -$6.38M | ||||||
Derivative Transactions0
No derivative transactions reported